Understanding temporal dynamics in tissue biology is key to linking transcriptomic snapshots to physiological function.

The exhibition aims to give a voice to people making creative work about their lives in a war zone. “These small notebooks and my pens became my refuge,” one wrote. The exhibition aims to give a voice ...

Apple on Tuesday dropped its new premium iPhones — the 17 Pro and 17 Pro Max — at its highly anticipated "Awe Dropping" event. Unfortunately for Apple, a large swath of the internet is not pleased ...

Multichain biotherapeutics continue to be a promising therapeutic modality. “These therapeutic recombinant proteins are typically assembled from at least three distinct polypeptide chains,” says ...

Adm. Daryl Caudle assumed the duties as the 34th Chief of Naval Operations on Aug. 25, 2025. US Navy photo WASHINGTON, D.C. — The Navy will roll out an updated fleet design that will integrate ...

President Donald Trump has selected Airbnb co-founder Joe Gebbia to spearhead a new federal design overhaul aimed at making government websites "both usable and beautiful." Gebbia, who joined the ...

Section 1. Purpose and Policy. America has long led the world in innovation, technological advancement, and design. But with a sprawling ecosystem of digital services offered to Americans, the ...

President Donald Trump called for improvements to federal government websites in a Thursday executive order, arguing the U.S. government “has lagged behind in usability and aesthetics.” The new ...

IMPROVING GOVERNMENT SERVICES: Today, President Donald J. Trump signed an Executive Order to launch the “America by Design” initiative, establishing the National Design Studio to enhance the usability ...

About six months after coming out of stealth with $50 million in funding, Latent Labs has released a web-based AI model for programming biology. Latent Labs‘ model has “achieved state-of-the-art in ...

A comparative study of the real-world safety and effectiveness of metronomic cyclophosphamide and bevacizumab with or without pembrolizumab for recurrent ovarian cancer. This is an ASCO Meeting ...